A double-blind placebo-controlled trial of topical benzydamine douche twice a day in patients with bacterial vaginosis

Hay, P. E.; Uthayakumar, S.; Lister, P.; Peddie, H.
December 1997
International Journal of STD & AIDS;Dec1997 Supplement 1, Vol. 8, p42
Academic Journal
The article cites a study to determine the efficacy of benzydamine douche as a treatment for bacterial vaginosis (BV). The therapy includes administration of 140 milliliter of 0.1% benzydamine douche twice a day for two weeks on fifteen women subjects recruited from a health center and employed a double blind randomized controlled trial. Results reflected that the efficacy of benzydamine is relative to the resolution of BV in women, as well as that of the placebo douche.


Related Articles

  • Oral prednisolone and naproxen: Equally effective for acute gout?  // Journal of Family Practice;Sep2008, Vol. 57 Issue 9, p576 

    The article presents findings on a randomized controlled trial which examines the effectiveness of oral prednisolone and naproxen in treating acute gout in the Netherlands. Patients involved in the study are not allowed to use nonsteroidal anti-inflammatory agents (NSAIDs), colchicine or other...

  • A randomised controlled trial of opioid only versus combined opioid and non-steroidal anti inflammatory analgesics for pain relief in the first 48 hours after Caesarean section. Adamou, Natalia; Tukur, Jamilu; Muhammad, Zakari; Galadanci, Hadiza // Nigerian Medical Journal;Sep/Oct2014, Vol. 55 Issue 5, p369 

    Background: Post-Caesarean section pain is complex in nature, requiring a combination of pharmacological and non-pharmacological methods. Effective management of postoperative pain will reduce postoperative morbidity, hospital stay and cost. The objective of this study was to compare the...

  • Celecoxib combined with esomeprazole prevented recurrent ulcer bleeding in patients with previous NSAID- induced ulcer bleeding.  // ACP Journal Club;Sept/Oct2007, Vol. 147 Issue 2, p38 

    The article reports on a study related with efficacy in preventing recurrent ulcer bleeding in patients with previous NonSteroidal AntiInflammatory Drug (NSAID)- induced ulcer bleeding. Treatment via combination of celecoxib and esomeprazole was compared with use of celecoxib alone. A randomized...

  • Parecoxib for analgesia after craniotomy. S. J. Jones; J. Cormack; M. A. Murphy; D. A. Scott // BJA: The British Journal of Anaesthesia;Jan2009, Vol. 102 Issue 1, p76 

    : Background Pain after craniotomy is often under-treated. Opiates carry distinct disadvantages. Non-steroidal anti-inflammatory drugs have an anti-platelet action and carry a bleeding risk. Cyclo-oxygenase 2 inhibitors such as parecoxib are not associated with a bleeding risk and would be...

  • Pozen Drug Meets Endpoints, but FDA Decision Awaited.  // BioWorld Today;12/4/2008, Vol. 19 Issue 235, p2 

    The article reveals that two Phase III trials of Pozen Incorporated's nonsteroidal anti-inflammatory drug (NSAID) met their primary endpoints, but the company must await a U.S. Food and Drug Administration (FDA) verdict on whether those endpoints are sufficient. Patients taking PN 400 consisting...

  • Do we Need a New Procedure for the Assessment of Adverse Events in Anti-migraine Clinical Trials? Amanzio, Martina // Recent Patents on CNS Drug Discovery;Jan2011, Vol. 6 Issue 1, p41 

    The large number of randomized controlled clinical trials on migraine have drawn the attention of some authors to the need to improve the design of such trials. In particular, adequate methodology is a critical issue in their planning and execution, as different methodological approaches can...

  • Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. Trelle, Sven; Reichenbach, Stephan; Wandel, Simon; Hildebrand, Pius; Tschannen, Beatrice; Villiger, Peter M.; Egger, Matthias; J√ľni, Peter // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;1/15/2011, Vol. 342 Issue 7789, p154 

    The article focuses on a meta-analysis of randomized controlled trials on the cardiovascular safety of non-steriodal antiinflammatory drugs. The meta-analysis included 31 trials the compared non-steroidal anti-inflammatory drugs head to head or with placebo, with at least 100 patient years of...

  • A 13-week, multicenter, randomized, double-blind study of lumiracoxib in hip osteoarthritis. Schnitzer, Thomas; Dattani, I.; Seriolo, Bruno; Schneider, Hartmut; Moore, Alan; Tseng, Lillian; Sallstig, Peter; Rebuli, Rosemary; Maxwell, Thomas // Clinical Rheumatology;Nov2011, Vol. 30 Issue 11, p1433 

    The aim of this 13-week, multicenter, randomized, double-blind, double-dummy, placebo- and positive-internal (celecoxib)-controlled, parallel-group study was to demonstrate the efficacy, safety, and tolerability of lumiracoxib in primary hip osteoarthritis (OA) patients. Eligible patients ( n =...

  • A prospective, randomized, comparative trial of a COX-2 selective nonsteroidal anti-inflammatory drug versus placebo in inguinal herniorrhaphy patients. Schurr, M.; Faucher, L. // Hernia;Oct2009, Vol. 13 Issue 5, p491 

    The standard opioid treatment for postoperative pain can be associated with nausea, vomiting, and constipation. In addition, opioids often provide insufficient pain relief. The purpose of this study was to compare postoperative pain and functional outcomes in patients undergoing inguinal...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics